Annual EBITDA:
-$493.48M-$36.80M(-8.06%)Summary
- As of today, CYTK annual EBITDA is -$493.48 million, with the most recent change of -$36.80 million (-8.06%) on December 31, 2024.
- During the last 3 years, CYTK annual EBITDA has fallen by -$309.78 million (-168.63%).
- CYTK annual EBITDA is now -1919.36% below its all-time high of $27.12 million, reached on December 31, 2009.
Performance
CYTK EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$107.82M+$28.31M(+20.80%)Summary
- As of today, CYTK quarterly EBITDA is -$107.82 million, with the most recent change of +$28.31 million (+20.80%) on June 30, 2025.
- Over the past year, CYTK quarterly EBITDA has increased by +$8.79 million (+7.54%).
- CYTK quarterly EBITDA is now -290.56% below its all-time high of $56.58 million, reached on June 30, 2009.
Performance
CYTK Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$504.83M+$8.79M(+1.71%)Summary
- As of today, CYTK TTM EBITDA is -$504.83 million, with the most recent change of +$8.79 million (+1.71%) on June 30, 2025.
- Over the past year, CYTK TTM EBITDA has dropped by -$45.16 million (-9.82%).
- CYTK TTM EBITDA is now -1838.21% below its all-time high of $29.04 million, reached on September 30, 2009.
Performance
CYTK TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CYTK EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -8.1% | +7.5% | -9.8% |
| 3Y3 Years | -168.6% | -1153.3% | -184.8% |
| 5Y5 Years | -430.4% | -252.8% | -571.6% |
CYTK EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -168.6% | at low | at high | +20.8% | -115.8% | +1.7% |
| 5Y | 5-Year | -468.6% | at low | -1686.0% | +20.8% | -571.6% | +1.7% |
| All-Time | All-Time | -1919.4% | at low | -290.6% | +20.8% | -1838.2% | +1.7% |
CYTK EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$107.82M(+20.8%) | -$504.83M(+1.7%) |
| Mar 2025 | - | -$136.13M(-8.9%) | -$513.62M(-4.1%) |
| Dec 2024 | -$493.48M(-8.1%) | -$125.04M(+7.9%) | -$493.48M(-2.4%) |
| Sep 2024 | - | -$135.84M(-16.5%) | -$481.94M(-4.8%) |
| Jun 2024 | - | -$116.61M(-0.5%) | -$459.67M(-0.7%) |
| Mar 2024 | - | -$115.99M(-2.2%) | -$456.48M(+0.0%) |
| Dec 2023 | -$456.68M(-37.6%) | -$113.50M(+0.1%) | -$456.68M(+1.3%) |
| Sep 2023 | - | -$113.57M(-0.1%) | -$462.64M(+2.4%) |
| Jun 2023 | - | -$113.42M(+2.4%) | -$474.20M(-28.4%) |
| Mar 2023 | - | -$116.20M(+2.7%) | -$369.39M(-11.3%) |
| Dec 2022 | -$331.99M(-80.7%) | -$119.45M(+4.5%) | -$331.99M(-41.9%) |
| Sep 2022 | - | -$125.14M(-1354.6%) | -$233.88M(-31.9%) |
| Jun 2022 | - | -$8.60M(+89.1%) | -$177.25M(+20.4%) |
| Mar 2022 | - | -$78.79M(-269.1%) | -$222.72M(-21.2%) |
| Dec 2021 | -$183.71M(-111.7%) | -$21.35M(+68.8%) | -$183.71M(+6.3%) |
| Sep 2021 | - | -$68.51M(-26.7%) | -$195.97M(-62.4%) |
| Jun 2021 | - | -$54.07M(-35.9%) | -$120.66M(-24.2%) |
| Mar 2021 | - | -$39.78M(-18.4%) | -$97.15M(-11.9%) |
| Dec 2020 | -$86.78M(+6.7%) | -$33.61M(-594.4%) | -$86.78M(-15.5%) |
| Sep 2020 | - | $6.80M(+122.2%) | -$75.16M(+28.1%) |
| Jun 2020 | - | -$30.56M(-3.9%) | -$104.53M(-5.2%) |
| Mar 2020 | - | -$29.41M(-33.8%) | -$99.36M(-6.8%) |
| Dec 2019 | -$93.04M(-11.4%) | -$21.98M(+2.6%) | -$93.04M(-1.6%) |
| Sep 2019 | - | -$22.57M(+11.1%) | -$91.61M(-7.3%) |
| Jun 2019 | - | -$25.39M(-10.0%) | -$85.36M(-4.6%) |
| Mar 2019 | - | -$23.09M(-12.3%) | -$81.64M(+1.8%) |
| Dec 2018 | -$83.49M(+23.3%) | -$20.56M(-25.9%) | -$83.17M(+14.9%) |
| Sep 2018 | - | -$16.32M(+24.7%) | -$97.75M(+10.0%) |
| Jun 2018 | - | -$21.67M(+12.0%) | -$108.62M(+2.2%) |
| Mar 2018 | - | -$24.62M(+30.0%) | -$111.10M(-2.0%) |
| Dec 2017 | -$108.87M(-647.3%) | -$35.14M(-29.2%) | -$108.88M(-65.9%) |
| Sep 2017 | - | -$27.20M(-12.6%) | -$65.64M(-1466.5%) |
| Jun 2017 | - | -$24.14M(-7.8%) | -$4.19M(-145.4%) |
| Mar 2017 | - | -$22.39M(-376.7%) | $9.22M(-53.7%) |
| Dec 2016 | $19.89M(+154.3%) | $8.09M(-76.4%) | $19.89M(+565.9%) |
| Sep 2016 | - | $34.25M(+419.1%) | $2.99M(+107.5%) |
| Jun 2016 | - | -$10.73M(+8.4%) | -$39.97M(-0.7%) |
| Mar 2016 | - | -$11.72M(-33.1%) | -$39.68M(-8.1%) |
| Dec 2015 | -$36.64M(-158.9%) | -$8.81M(-1.2%) | -$36.72M(-90.8%) |
| Sep 2015 | - | -$8.70M(+16.7%) | -$19.24M(-17.2%) |
| Jun 2015 | - | -$10.44M(-19.1%) | -$16.41M(-15.1%) |
| Mar 2015 | - | -$8.76M(-201.1%) | -$14.26M(-0.7%) |
| Dec 2014 | -$14.16M(+57.5%) | $8.67M(+247.6%) | -$14.16M(+12.2%) |
| Sep 2014 | - | -$5.87M(+29.1%) | -$16.13M(+29.2%) |
| Jun 2014 | - | -$8.29M(+4.4%) | -$22.76M(+22.6%) |
| Mar 2014 | - | -$8.66M(-229.4%) | -$29.43M(+11.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$33.28M(+16.3%) | $6.70M(+153.5%) | -$33.28M(+35.1%) |
| Sep 2013 | - | -$12.51M(+16.3%) | -$51.31M(-5.4%) |
| Jun 2013 | - | -$14.95M(-19.4%) | -$48.70M(-14.4%) |
| Mar 2013 | - | -$12.52M(-10.6%) | -$42.58M(-7.0%) |
| Dec 2012 | -$39.78M(+14.5%) | -$11.33M(-14.4%) | -$39.80M(+0.8%) |
| Sep 2012 | - | -$9.90M(-12.2%) | -$40.12M(+1.2%) |
| Jun 2012 | - | -$8.82M(+9.5%) | -$40.59M(+9.8%) |
| Mar 2012 | - | -$9.75M(+16.3%) | -$45.00M(+3.3%) |
| Dec 2011 | -$46.52M(+1.8%) | -$11.64M(-12.2%) | -$46.52M(-1.1%) |
| Sep 2011 | - | -$10.38M(+21.6%) | -$46.01M(+3.5%) |
| Jun 2011 | - | -$13.23M(-17.3%) | -$47.66M(-1.3%) |
| Mar 2011 | - | -$11.27M(-1.3%) | -$47.04M(+0.8%) |
| Dec 2010 | -$47.40M(-274.8%) | -$11.13M(+7.5%) | -$47.40M(+1.4%) |
| Sep 2010 | - | -$12.03M(+4.5%) | -$48.06M(-10.2%) |
| Jun 2010 | - | -$12.61M(-8.4%) | -$43.63M(-270.7%) |
| Mar 2010 | - | -$11.63M(+1.4%) | $25.56M(-5.8%) |
| Dec 2009 | $27.12M(+150.8%) | -$11.79M(-55.3%) | $27.12M(-6.6%) |
| Sep 2009 | - | -$7.59M(-113.4%) | $29.04M(+26.1%) |
| Jun 2009 | - | $56.58M(+661.9%) | $23.04M(+147.1%) |
| Mar 2009 | - | -$10.07M(-2.0%) | -$48.95M(+8.4%) |
| Dec 2008 | -$53.43M(+0.4%) | -$9.87M(+27.4%) | -$53.43M(+7.7%) |
| Sep 2008 | - | -$13.60M(+11.7%) | -$57.85M(-1.9%) |
| Jun 2008 | - | -$15.40M(-5.8%) | -$56.78M(-2.9%) |
| Mar 2008 | - | -$14.55M(-1.8%) | -$55.20M(-2.9%) |
| Dec 2007 | -$53.66M(+8.1%) | -$14.30M(-14.1%) | -$53.66M(+3.6%) |
| Sep 2007 | - | -$12.53M(+9.3%) | -$55.63M(+4.7%) |
| Jun 2007 | - | -$13.82M(-6.2%) | -$58.38M(+0.6%) |
| Mar 2007 | - | -$13.01M(+20.1%) | -$58.70M(-0.5%) |
| Dec 2006 | -$58.41M(-40.5%) | -$16.27M(-6.5%) | -$58.41M(-10.0%) |
| Sep 2006 | - | -$15.28M(-8.0%) | -$53.09M(-11.1%) |
| Jun 2006 | - | -$14.14M(-11.2%) | -$47.78M(-8.7%) |
| Mar 2006 | - | -$12.72M(-16.1%) | -$43.97M(-5.8%) |
| Dec 2005 | -$41.57M(-18.2%) | -$10.95M(-9.9%) | -$41.57M(+1.2%) |
| Sep 2005 | - | -$9.97M(+3.5%) | -$42.09M(-0.3%) |
| Jun 2005 | - | -$10.33M(-0.1%) | -$41.95M(-4.0%) |
| Mar 2005 | - | -$10.32M(+10.1%) | -$40.33M(-14.7%) |
| Dec 2004 | -$35.16M(-19.5%) | -$11.47M(-16.7%) | -$35.16M(+45.2%) |
| Sep 2004 | - | -$9.83M(-12.9%) | -$64.21M(-24.1%) |
| Jun 2004 | - | -$8.71M(-69.1%) | -$51.73M(-8.3%) |
| Mar 2004 | - | -$5.15M(+87.3%) | -$47.76M(-0.3%) |
| Dec 2003 | -$29.41M(-39.2%) | -$40.52M(-1632.6%) | -$47.62M(-571.1%) |
| Sep 2003 | - | $2.64M(+155.9%) | -$7.09M(+27.1%) |
| Jun 2003 | - | -$4.73M(+5.5%) | -$9.74M(-94.5%) |
| Mar 2003 | - | -$5.01M | -$5.01M |
| Dec 2002 | -$21.13M(-14.9%) | - | - |
| Dec 2001 | -$18.39M(-33.3%) | - | - |
| Dec 2000 | -$13.79M | - | - |
FAQ
- What is Cytokinetics, Incorporated annual EBITDA?
- What is the all-time high annual EBITDA for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated annual EBITDA year-on-year change?
- What is Cytokinetics, Incorporated quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated quarterly EBITDA year-on-year change?
- What is Cytokinetics, Incorporated TTM EBITDA?
- What is the all-time high TTM EBITDA for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated TTM EBITDA year-on-year change?
What is Cytokinetics, Incorporated annual EBITDA?
The current annual EBITDA of CYTK is -$493.48M
What is the all-time high annual EBITDA for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high annual EBITDA is $27.12M
What is Cytokinetics, Incorporated annual EBITDA year-on-year change?
Over the past year, CYTK annual EBITDA has changed by -$36.80M (-8.06%)
What is Cytokinetics, Incorporated quarterly EBITDA?
The current quarterly EBITDA of CYTK is -$107.82M
What is the all-time high quarterly EBITDA for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high quarterly EBITDA is $56.58M
What is Cytokinetics, Incorporated quarterly EBITDA year-on-year change?
Over the past year, CYTK quarterly EBITDA has changed by +$8.79M (+7.54%)
What is Cytokinetics, Incorporated TTM EBITDA?
The current TTM EBITDA of CYTK is -$504.83M
What is the all-time high TTM EBITDA for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high TTM EBITDA is $29.04M
What is Cytokinetics, Incorporated TTM EBITDA year-on-year change?
Over the past year, CYTK TTM EBITDA has changed by -$45.16M (-9.82%)